Molecular Docking and ADMET Profiling of Plant-Derived Flavonoids as Potential Anti-Diabetic Agents
DOI:
https://doi.org/10.5281/zenodo.22637939Keywords:
flavonoids, molecular docking, ADMET, alpha-glucosidase, type 2 diabetesAbstract
Background: Type 2 diabetes management increasingly looks to plant-derived flavonoids as multi-target scaffolds, and
computational screening has become the first filter for prioritising candidates. Objective: This review synthesises published
molecular docking and ADMET/pharmacokinetic studies of common dietary flavonoids against four validated anti-diabetic
targets. Methods: We narratively reviewed peer-reviewed docking and ADMET reports on quercetin, kaempferol, myricetin,
naringenin, epicatechin, rutin, hesperidin and related flavonoids against alpha-glucosidase, alpha-amylase, DPP-4 and
PPAR-gamma. Findings: Reported binding energies cluster near -7 to -9 kcal/mol, generally exceeding metformin, but oral
bioavailability and rule-of-five violations remain limiting. Conclusions: Structural optimisation and delivery strategies are needed
to translate favourable in silico profiles into clinical efficacy.
References
Murota K, Nakamura Y, Uehara M. Flavonoid metabolism: the interaction of metabolites and gut microbiota. Biosci Biotechnol Biochem. 2018;82(4):600-610. doi:10.1080/09168451.2018.1444467
Lam TP, Tran NVN, Pham LHD, Lai NVT, Dang BTN, Truong NLN, Nguyen-Vo SK, Hoang TL, Mai TT, Tran TD. Flavonoids as dual-target inhibitors against alpha-glucosidase and alpha-amylase: a systematic review of in vitro studies. Nat Prod Bioprospect. 2024;14:1. doi:10.1007/s13659-023-00424-w
Ostadmohammadi V, Milajerdi A, Ayati E, Kolahdooz F, Asemi Z. Effects of quercetin supplementation on glycemic control among patients with metabolic syndrome and related disorders: a systematic review and meta-analysis of randomized controlled trials. Phytother Res. 2019;33(5):1330-1340. doi:10.1002/ptr.6334
Jhong CH, Riyaphan J, Lin SH, Chia YC, Weng CF. Screening alpha-glucosidase and alpha-amylase inhibitors from natural compounds by molecular docking in silico. BioFactors. 2015;41(4):242-251. doi:10.1002/biof.1219
Kim JS, Kwon CS, Son KH. Inhibition of alpha-glucosidase and amylase by luteolin, a flavonoid. Biosci Biotechnol Biochem. 2000;64(11):2458-2461. doi:10.1271/bbb.64.2458
Hua F, Zhou P, Wu HY, Chu GX, Xie ZW, Bao GH. Inhibition of alpha-glucosidase and alpha-amylase by flavonoid glycosides from Lu'an GuaPian tea: molecular docking and interaction mechanism. Food Funct. 2018;9(8):4173-4183. doi:10.1039/c8fo00562a
Trott O, Olson AJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. 2010;31(2):455-461. doi:10.1002/jcc.21334
Daina A, Michielin O, Zoete V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep. 2017;7:42717. doi:10.1038/srep42717
Pires DEV, Blundell TL, Ascher DB. pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. J Med Chem. 2015;58(9):4066-4072. doi:10.1021/acs.jmedchem.5b00104
Kahksha, Alam O, Al-Keridis LA, Khan J, Naaz S, Alam A, Ashraf SA, Alshammari N, Adnan M, Beg MA. Evaluation of antidiabetic effect of luteolin in STZ induced diabetic rats: molecular docking, molecular dynamics, in vitro and in vivo studies. J Funct Biomater. 2023;14(3):126. doi:10.3390/jfb14030126
Proenca C, Freitas M, Ribeiro D, Tome SM, Oliveira EFT, Viegas MF, Araujo AN, Ramos MJ, Silva AMS, Fernandes PA, Fernandes E. Evaluation of a flavonoids library for inhibition of pancreatic alpha-amylase towards a structure-activity relationship. J Enzyme Inhib Med Chem. 2019;34(1):577-588. doi:10.1080/14756366.2018.1558221
Ahmed S, Ali MC, Ruma RA, Mahmud S, Paul GK, Saleh MA, Alshahrani MM, Obaidullah AJ, Biswas SK, Rahman MM, Rahman MM, Islam MA. Molecular docking and dynamics simulation of natural compounds from betel leaves (Piper betle L.) for investigating the potential inhibition of alpha-amylase and alpha-glucosidase of type 2 diabetes. Molecules. 2022;27(14):4526. doi:10.3390/molecules27144526
Kaliaperumal K, Zhang L, Gao L, Xiong Q, Liang Y, Jiang Y, Zhang J. Insight into the inhibitory mechanisms of hesperidin on alpha-glucosidase through kinetics, fluorescence quenching, and molecular docking studies. Foods. 2023;12(22):4142. doi:10.3390/foods12224142
McMillan J, Bester MJ, Apostolides Z. In silico docking and ADMET studies on clinical targets for type 2 diabetes correlated to in vitro inhibition of pancreatic alpha-amylase and alpha-glucosidase by rutin, caffeic acid, p-coumaric acid, and vanillin. In Silico Pharmacol. 2025;13:42. doi:10.1007/s40203-025-00324-6
Pan J, Zhang Q, Zhang C, Yang W, Liu H, Lv Z, Liu J, Jiao Z. Inhibition of dipeptidyl peptidase-4 by flavonoids: structure-activity relationship, kinetics and interaction mechanism. Front Nutr. 2022;9:892426. doi:10.3389/fnut.2022.892426
Lalitha N, Sadashivaiah B, Ramaprasad TR, Singh SA. Anti-hyperglycemic activity of myricetin, through inhibition of DPP-4 and enhanced GLP-1 levels, is attenuated by co-ingestion with lectin-rich protein. PLOS ONE. 2020;15(4):e0231543. doi:10.1371/journal.pone.0231543
Meduru H, Wang YT, Tsai JJP, Chen YC. Finding a potential dipeptidyl peptidase-4 (DPP-4) inhibitor for type-2 diabetes treatment based on molecular docking, pharmacophore generation, and molecular dynamics simulation. Int J Mol Sci. 2016;17(6):920. doi:10.3390/ijms17060920
Baranowska J, Kiss A, Szeleszczuk Ł. Molecular docking of natural compounds as DPP-4 inhibitors in type 2 diabetes: a comprehensive review. Pharmaceutics. 2026;18(6):741. doi:10.3390/pharmaceutics18060741
Salam NK, Huang THW, Kota BP, Kim MS, Li Y, Hibbs DE. Novel PPAR-gamma agonists identified from a natural product library: a virtual screening, induced-fit docking and biological assay study. Chem Biol Drug Des. 2008;71(1):57-70. doi:10.1111/j.1747-0285.2007.00606.x
Singh AK, Raj V, Keshari AK, Rai A, Kumar P, Rawat A, Maity B, Kumar D, Prakash A, De A, Samanta A, Bhattacharya B, Saha S. Isolated mangiferin and naringenin exert antidiabetic effect via PPARgamma/GLUT4 dual agonistic action with strong metabolic regulation. Chem Biol Interact. 2018;280:33-44. doi:10.1016/j.cbi.2017.12.007
Yoshida H, Tsuhako R, Atsumi T, Narumi K, Watanabe W, Sugita C, Kurokawa M. Naringenin interferes with the anti-diabetic actions of pioglitazone via pharmacodynamic interactions. J Nat Med. 2017;71(2):442-448. doi:10.1007/s11418-016-1063-4
Moon DO. Plant-derived flavonoids as AMPK activators: unveiling their potential in type 2 diabetes management through mechanistic insights, docking studies, and pharmacokinetics. Appl Sci. 2024;14(19):8607. doi:10.3390/app14198607
Bitew M, Desalegn T, Demissie TB, Belayneh A, Endale M, Eswaramoorthy R. Pharmacokinetics and drug-likeness of antidiabetic flavonoids: molecular docking and DFT study. PLOS ONE. 2021;16(12):e0260853. doi:10.1371/journal.pone.0260853
Graefe EU, Wittig J, Mueller S, Riethling AK, Uehleke B, Drewelow B, Pforte H, Jacobasch G, Derendorf H, Veit M. Pharmacokinetics and bioavailability of quercetin glycosides in humans. J Clin Pharmacol. 2001;41(5):492-499. doi:10.1177/00912700122010366
Moon YJ, Wang L, DiCenzo R, Morris ME. Quercetin pharmacokinetics in humans. Biopharm Drug Dispos. 2008;29(4):205-217. doi:10.1002/bdd.605
Barve A, Chen C, Hebbar V, Desiderio J, Saw CL, Kong AN. Metabolism, oral bioavailability and pharmacokinetics of chemopreventive kaempferol in rats. Biopharm Drug Dispos. 2009;30(7):356-365. doi:10.1002/bdd.677
Zeng H, Liu C, Wan L, Peng L, Wen S, Fang W, Chen H, Wang K, Yang X, Huang J, Liu Z. (-)-Epicatechin ameliorates type 2 diabetes mellitus by reshaping the gut microbiota and Gut-Liver axis in GK rats. Food Chem. 2024;447:138916. doi:10.1016/j.foodchem.2024.138916
